gavin
Topics Engaged In
-
- Topic
- Voices
- Posts
- Last Post
-
-
Survived very long
Started by:
in: Survivor Stories
- 5
- 6
- 4 years, 7 months ago
-
A Translational Approach to Standardization of Machine Perfusion Adoption in Ex
Started by:
in: Surgery, Resection & Transplant Treatment Options
- 1
- 1
- 4 years, 7 months ago
-
Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic
Started by:
in: Radiation Treatments & Options
- 1
- 1
- 4 years, 7 months ago
-
A Phase 3, First Line Study of Pemigatinib vs Gemcitabine/Cisplatin in Patients
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 7 months ago
-
Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing C
Started by:
in: New Developments
- 1
- 1
- 4 years, 7 months ago
-
Bile and urine peptide marker profiles: access keys to molecular pathways and bi
Started by:
in: New Developments
- 1
- 1
- 4 years, 7 months ago
-
Phenotypic and potential functional characteristics of different immune cells ex
Started by:
in: New Developments
- 1
- 1
- 4 years, 7 months ago
-
Anyone Have Treatment with 5Fu Monotherapy?
Started by:
in: Good News / What’s Working
- 3
- 3
- 4 years, 7 months ago
-
Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinom
Started by:
in: New Developments
- 1
- 1
- 4 years, 7 months ago
-
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 7 months ago
-
FGFR2 fusions in iCCA
Started by:
in: Websites
- 1
- 1
- 4 years, 7 months ago
-
In Loving Memory of My Dad, 10 years ago today.
Started by:
in: In Remembrance
- 3
- 3
- 4 years, 7 months ago
-
Immune contexture of cholangiocarcinoma.
Started by:
in: New Developments
- 1
- 1
- 4 years, 7 months ago
-
Molecular classification of cholangiocarcinoma.
Started by:
in: New Developments
- 1
- 1
- 4 years, 7 months ago
-
Survived very long
